Gastroesophageal Junction Cancer

DBCOND0043630Digestive System DiseasesNeoplasms

Gastroesophageal Junction Cancer is the indication for 2 drugs in DrugBank. It is covered by 2 curated, structured indications.

Also known as
GE Junction Cancer · Gastro-esophageal Junction Cancer · Neoplasm of Cardioesophageal Junction · Cancer of Esophagogastric Junction · Esophagogastric Junction Cancer
Classified under
Indicated drugs

Resolves to

Vocabularies
SNOMED CT154441003MedDRA10007425UMLSC0152018

What you can answer from here — as of October 22, 2026

2Indicated drugsWith each drug's targets and mechanism
Listed above
2Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
117Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which approved drugs for Gastroesophageal Junction Cancer share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In